Cardiac cell culture material
Publication number
Assignee
LYMPHOGENIX LTD
Application Domain
Peptide/protein ingredients
Microorganisms
Skeletal/connective tissue cells
Publication Date
31 Oct 2023
Patent Value
$2,910,000
Abstract
The purpose of the present invention is to provide a cardiac cell culture material which specifically acts on cardiac cells. In addition, another purpose of the present invention is to provide artificial organ material obtained by culturing by using said cardiac cell culture material, and a method for producing the same. Thus, provided is a cardiac cell culture, wherein functional cardiac tissue is favorably built by using a cardiac cell culture material containing VCAM-1.
Technical Problem Summary
The challenge lies in selectively isolating cardiac fibroblasts that specifically interact with cardiac cells, as their function and molecular mechanisms are not well understood, hindering the development of effective cardiac tissue engineering and regenerative medicine.
Benefit Summary
This approach allows for the creation of functional cardiac tissue with improved cardiomyocyte proliferation and tissue formation, demonstrating the importance of VCAM-1 in cardiac cell interactions and tissue engineering.